ENDO 2022
Management of hyperglycemia for hospitalized patients
www.high5endocrinology.tv | Meeting coverage | ENDO 2022
Diabetes and obesity
ENDO 2022
Management of hyperglycemia for hospitalized patients
ENDO 2022
Glucagon / GLP-1 agonist to treat obesity - a…
ENDO 2022
ANGPTL3 - New kid on the block?
ENDO 2022
Glucagon / GLP-1 agonist to treat obesity - a dose-finding study
ENDO 2022
ANGPTL3 - New kid on the block?
Transgender
ENDO 2022
Bone mineral density under GnRH agonists
ENDO 2022
Bone mineral density under GnRH agonists
DSD / AGS
ENDO 2022
Complete androgen insensitivity syndrome: MRI screening…
ENDO 2022
CRF1 receptor antagonist beneficial for adjustment of…
ENDO 2022
Complete androgen insensitivity syndrome: MRI screening to exclude malignoma
ENDO 2022
CRF1 receptor antagonist beneficial for adjustment of AGS?
Parathyroid
ENDO 2022
Update: Guideline on hyperparathyroidism 2022
ENDO 2022
Update: Guideline on hypoparathyroidism 2022
ENDO 2022
Update: Guideline on hyperparathyroidism 2022
ENDO 2022
Update: Guideline on hypoparathyroidism 2022
Neuroendocrinology and pituitary
ENDO 2022
Addiction to wireless mobile device and obesity
ENDO 2022
Central diabetes insipidus from a patient's perspective
ENDO 2022
Weight trajectory as a predictor of cushing’s disease
ENDO 2022
Addiction to wireless mobile device and obesity
ENDO 2022
Central diabetes insipidus from a patient's perspective
ENDO 2022
Weight trajectory as a predictor of cushing’s disease
Calcium and bone
ENDO 2022
Iron and phosphate metabolism
ENDO 2022
Iron and phosphate metabolism
